Header Logo

Fadi Chalhoub

Concepts (71)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pacemaker, Artificial
4
2024
49
3.180
 Why?
Thromboembolism
3
2024
72
1.010
 Why?
Anticoagulants
4
2024
493
0.920
 Why?
Perioperative Care
2
2024
84
0.890
 Why?
Catheter Ablation
4
2022
153
0.860
 Why?
Syncope, Vasovagal
1
2023
8
0.840
 Why?
High-Frequency Jet Ventilation
1
2022
2
0.770
 Why?
High-Frequency Ventilation
1
2022
5
0.760
 Why?
Atrial Fibrillation
6
2024
831
0.760
 Why?
Defibrillators, Implantable
1
2024
265
0.720
 Why?
Patient Discharge
1
2022
505
0.610
 Why?
Cardiac Pacing, Artificial
3
2023
37
0.600
 Why?
Administration, Oral
2
2024
365
0.240
 Why?
Hematoma
1
2024
77
0.220
 Why?
Treatment Outcome
5
2022
5556
0.220
 Why?
Hypotension
1
2024
50
0.210
 Why?
Body Surface Potential Mapping
2
2013
4
0.210
 Why?
Equipment Design
2
2022
348
0.200
 Why?
Heart Conduction System
2
2013
53
0.200
 Why?
Equipment Failure
1
2022
65
0.200
 Why?
Tidal Volume
1
2022
41
0.190
 Why?
Humans
10
2024
62541
0.180
 Why?
Hypertension
2
2024
590
0.170
 Why?
Prospective Studies
3
2022
3248
0.150
 Why?
Pandemics
1
2022
661
0.140
 Why?
Thiophenes
1
2014
29
0.110
 Why?
Middle Aged
6
2024
17298
0.110
 Why?
Morpholines
1
2014
89
0.110
 Why?
Cardiac Catheters
1
2012
11
0.100
 Why?
Electrodes, Implanted
1
2012
37
0.100
 Why?
Heart Atria
1
2013
138
0.100
 Why?
beta-Alanine
1
2012
8
0.100
 Why?
Benzimidazoles
1
2012
54
0.090
 Why?
Registries
2
2014
870
0.090
 Why?
Image Enhancement
1
2012
191
0.090
 Why?
Aged
4
2022
14206
0.090
 Why?
Warfarin
1
2012
109
0.090
 Why?
Imaging, Three-Dimensional
1
2013
287
0.090
 Why?
Software
1
2013
381
0.080
 Why?
Algorithms
1
2013
1003
0.070
 Why?
Feasibility Studies
3
2014
562
0.060
 Why?
Angiotensinogen
1
2024
3
0.060
 Why?
Antihypertensive Agents
1
2024
171
0.050
 Why?
Double-Blind Method
1
2024
738
0.050
 Why?
Blood Pressure
1
2024
513
0.050
 Why?
RNA Interference
1
2024
618
0.040
 Why?
RNA
1
2024
422
0.040
 Why?
Sensitivity and Specificity
2
2013
1139
0.040
 Why?
Reproducibility of Results
2
2013
1637
0.040
 Why?
Male
5
2024
29387
0.040
 Why?
Follow-Up Studies
2
2014
2441
0.030
 Why?
Female
5
2024
32398
0.030
 Why?
Postoperative Complications
2
2014
1260
0.030
 Why?
Perioperative Period
1
2014
20
0.030
 Why?
Rivaroxaban
1
2014
19
0.030
 Why?
Factor Xa Inhibitors
1
2014
35
0.030
 Why?
Equipment Failure Analysis
1
2012
75
0.020
 Why?
Dabigatran
1
2012
20
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
861
0.020
 Why?
Swine
1
2012
368
0.020
 Why?
Anti-Arrhythmia Agents
1
2012
99
0.020
 Why?
Secondary Prevention
1
2012
163
0.020
 Why?
Hemorrhage
1
2012
266
0.020
 Why?
Sex Factors
1
2012
969
0.020
 Why?
Electrocardiography
1
2012
549
0.020
 Why?
Echocardiography
1
2012
498
0.020
 Why?
Incidence
1
2012
1359
0.020
 Why?
Age Factors
1
2012
1553
0.020
 Why?
Adult
1
2024
16575
0.020
 Why?
Retrospective Studies
1
2012
6489
0.010
 Why?
Animals
1
2012
20570
0.010
 Why?
Chalhoub's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_